Radiofrequency Ablation of Renal Tumors: Four-Year Follow-Up Results in 47 Patients
| Autor: | Seong Guk Yoon, Soo Dong Kim, Gyung Tak Sung |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2012 |
| Předmět: |
Adult
Male Reoperation medicine.medical_specialty Percutaneous Radiofrequency ablation Radiography medicine.medical_treatment Follow up results Contrast Media Physical examination law.invention chemistry.chemical_compound Postoperative Complications Minimally invasive surgical procedures law Biopsy medicine Humans Radiology Nuclear Medicine and imaging Aged Retrospective Studies Creatinine medicine.diagnostic_test business.industry Middle Aged Ablation Magnetic Resonance Imaging Kidney Neoplasms Kidney tumors surgical procedures operative Treatment Outcome chemistry Catheter Ablation Original Article Female Laparoscopy Radiography Thoracic Radiology Neoplasm Recurrence Local business Tomography X-Ray Computed Follow-Up Studies |
| Zdroj: | Korean Journal of Radiology |
| ISSN: | 2005-8330 1229-6929 |
| Popis: | OBJECTIVE To retrospectively evaluate the intermediate results of radiofrequency ablation (RFA) of small renal masses (SRMs). MATERIALS AND METHODS Percutaneous or laparoscopic RFA was performed on 48 renal tumors in 47 patients. The follow-up studies included a physical examination, chest radiography, creatinine level, and contrast-enhanced CT or MRI. To confirm the pathologic criteria of complete ablation, 35 patients underwent a follow-up biopsy. Recurrence was defined as contrast enhancement on imaging studies after 3 months, lesion growth at subsequent imaging, or viable cancer cells on follow-up biopsy. RESULTS Technical success was achieved in 43 (89.6%) of 48 renal tumors. The mean tumor size was 2.3 cm and the mean follow-up period was 49.6 months. Repeated RFA was necessary in 5 tumors due to incomplete ablation. The overall complication rate was 35.8%, of which 96.2% were mild complications. Serum creatinine levels at 12 months after RFA did not differ from those before RFA (1.28 vs. 1.36 mg/dL). Four patients were found to have recurrence at various follow-up intervals, and distant metastasis was not found in any cases. CONCLUSION RFA appears to be a useful treatment for selected patients with SRMs. Our 4-year follow-up results disclose an excellent therapeutic outcome with RFA, while achieving effective local tumor control. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|